Prosecution Insights
Last updated: October 02, 2026

Examiner: GONZALEZ, LEI NMN

Tech Center 3700 • Art Units: 3783

This examiner grants 43% of resolved cases

Analysis

Lei NMN Gonzalez examines cases in Tech Center 3700 and Art Unit 3783. There are 20 resolved cases in the data. The allowance rate is 45.0 percent. This percentage indicates the frequency of grants within this docket for applications reaching a final resolution, providing a baseline for the probability of success.

The interview lift is 50.0 percent. This figure is very large when compared to the 45.0 percent allowance rate, suggesting that interviews are an exceptionally effective tool for improving outcomes. Practitioners should prioritize direct engagement to resolve outstanding issues and clarify technical disagreements, as supported by the 20 resolved cases recorded in this docket.

The median time to allowance is 1432 days. This duration represents the typical prosecution cycle for granted patents. While the data is based on 20 resolved cases, the 50.0 percent interview lift provides a clear strategic recommendation for applicants seeking to improve their chances of a patent grant, providing a reliable basis for strategy and expectation management.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

42.9%
Allow Rate
-27.1% vs TC avg
68
Total Applications
+51.8%
Interview Lift
1449
Avg Prosecution Days
Based on 21 resolved cases, 2023–2026

Rejection Statute Breakdown

0.3%
§101 Eligibility
27.9%
§102 Novelty
51.1%
§103 Obviousness
20.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17716675 Catheter Placement System with Splittable Anchor Final Rejection Bard Access Systems, Inc.
17595679 WET JET DEBRIDEMENT AND WOUND BED PREPARATION Non-Final OA SMITH & NEPHEW ASIA PACIFIC PTE. LIMITED
18055895 AUTO-INJECTOR AND RELATED METHODS OF USE Non-Final OA Regeneron Pharmaceuticals, Inc.
18530918 NEEDLE-FREE CONNECTORS Non-Final OA CareFusion 303, Inc.
18353606 FLOW RESTRICTION ADAPTER FOR RESTRICTING HEMOLYSIS Non-Final OA CareFusion 303, Inc.
18037139 FORMULATIONS, METHODS, AND PRE-FILLED INJECTION DEVICES WITHOUT FATTY ACID PARTICLES Non-Final OA W. L. Gore & Associates, Inc.
17945585 BIOACTIVE RELEASING MEMBRANE FOR ANALYTE SENSOR Non-Final OA DexCom, Inc.
18235098 MULTIPLE DELIVERY FLUSH SYRINGE Final Rejection Becton, Dickinson and Company
18203127 Container Closure with Reverse Coefficient of Thermal Expansion Materials Final Rejection Becton, Dickinson and Company
17921276 Supplemental Device for an Injection Device Final Rejection Sanofi
18209120 INFUSION PUMP Final Rejection TERUMO KABUSHIKI KAISHA
18306041 COMPRESSION DETECTION AND COMPENSATION FOR A BIOLOGICAL SENSOR SECURED TO A USER Final Rejection Insulet Corporation
18644435 AUTOINJECTOR NEEDLE-HOUSING ASSEMBLY Non-Final OA SHL Medical AG
18703140 AN INFUSION SUBASSEMBLY AND AN INFUSION ASSEMBLY Non-Final OA SHL Medical AG
17924362 ACCESSORY DEVICE FOR A CATHETER Non-Final OA Coloplast A/S

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month